Please login to the form below

Not currently logged in
Email:
Password:

Penn Pharma begins £12m expansion

Penn Pharma has completed the first phase of its £12m expansion programme by investing £315k in extending its facilities

Partly backed by the Welsh Assembly Government's Single Investment Fund, Penn Pharma has completed the first phase of its £12m expansion programme by investing £315k in extending its facilities by 2400m2 and changing the transport and delivery infrastructure at its Tredegar headquarters. 

Peter George, CEO of Penn Pharma, said: "By heavily investing in our Tredegar site it strengthens our commitment to the local community and, as a leading Welsh company, we will endeavour to pay back the Assembly Government's faith in us by driving sustainable growth and employment."

Penn, founded 30 years ago, is a highly specialised pharmaceutical company which combines an integrated pharmaceutical development service with low volume clinical and commercial manufacturing. Its services support a fast and effective route from clinic to market. The company has achieved very strong growth in recent years, with customers from many of the world's leading pharmaceutical companies in the UK, EU and USA.
 
The company plans to roll out its £12m expansion plans over the next five years.

2nd November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics